ADVANCED ONCOTHER.
ADVANCED ONCOTHER.
Share · GB00BD6SX109 · A2AL9X (XLON)
Overview Financial Indicators
No Price
n/a

Performance

Day Week Month 3 Months 6 Months 1 Year 5 Years
- - - - 0,00 % 0,00 % -99,93 %

Company Profile for ADVANCED ONCOTHER. Share

Advanced Oncotherapy plc, together with its subsidiaries, engages in the designing, assembling, and selling proton-based radiotherapy systems for treatment of cancer. It is developing Linac Image Guided Hadron Technology, a proton therapy system for treating cancer. The company also engages in the management of healthcare related properties. It has operations in the United Kingdom, Switzerland, and the United States. The company was formerly known as CareCapital Group plc and changed its name to Advanced Oncotherapy PLC in September 2012. Advanced Oncotherapy plc was founded in 1994 and is headquartered in London, the United Kingdom.

Company Data

Name ADVANCED ONCOTHER.
Company Advanced Oncotherapy plc
Website https://www.avoplc.com
Primary Exchange XLON London
WKN A2AL9X
ISIN GB00BD6SX109
Asset Class Share
Sector Healthcare
Industry Medical - Devices
CEO Mr. Nicolas Serandour
Country United Kingdom
Currency GBP
Employees 0,2 T
Address 4 Tenterden Street, W1S 1TE London
IPO Date 2006-08-04

Stock Splits

Date Split
01.07.2016 1:25

Ticker Symbols

Name Symbol
London AVO.L

More Shares

Investors who ADVANCED ONCOTHER. hold also have the following shares in their portfolio:
GLENCORE FIN. (CA) 12/42
GLENCORE FIN. (CA) 12/42 Bond
MEXICO 16/26 MTN
MEXICO 16/26 MTN Bond
The financial platform MoneyPeak tracks and analyzes investments and portfolios. From securities portfolios to crypto purchases.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.
Imprint Data Protection Blog Community Feedback Changelog
Im App Store herunterladen Bei Google Play herunterladen
All rights reserved © LCP GmbH 2025